Stockholders' Deficit (Details) - USD ($)							1 Months Ended		3 Months Ended		12 Months Ended
	Nov. 04, 2021	Jun. 14, 2021	Jun. 09, 2021	May 03, 2021	Aug. 06, 2019	Nov. 09, 2017	Dec. 17, 2021	Dec. 20, 2017	Dec. 31, 2021	Dec. 31, 2020	Sep. 30, 2021	Jan. 30, 2019
Stockholders' Deficit (Details) [Line Items]
Preferred stock designations amount									4,999,750
Common stock dividend (in Dollars per share)									$ 0.99
Common stock, shares authorized									6,000,000,000		6,000,000,000
Common stock, shares outstanding									2,693,360,585		2,470,510,585
Issuance settled amount due, description			the Company submitted a third registration statement filed on Form S-1. The Company requested accelerated status and the registration statement became effective on June 22, 2021. The offering provides for the issuance of up to 1,500,000,000 shares of common stock at a price of $.0025, under subscriptions.
Common stock, shares issued											100,000,000
Common stock, shares value (in Dollars)											$ 250,000
Geneva Roth Remark Holdings Inc. [Member]
Stockholders' Deficit (Details) [Line Items]
Principal amount (in Dollars)	$ 58,500						$ 58,500
Accrued interest (in Dollars)	$ 2,925						$ 2,925
Common stock conversion		81,900,000		40,950,000
Interest expense (in Dollars)		$ 0		$ 0
Stock Incentive Plan [Member]
Stockholders' Deficit (Details) [Line Items]
Stock incentive plan, description									The Company established its 2016 Stock Incentive Plan (the “Plan”) that permits the granting of incentive stock options and other common stock awards. The maximum number of shares available under the Plan is 100,000 shares. The Plan is open to all employees, officers, directors, and non-employees of the Company. Options granted under the Plan will terminate and may no longer be exercised (i) immediately upon termination of an employee or consultant for cause or (ii) one year after termination of employment, but not later than the remaining term of the option. As of December 31, 2021, 82,777 awards remain available for grant under the Plan.
Employee [Member]
Stockholders' Deficit (Details) [Line Items]
Agreement, description						the Company received a first tranche payment of $75,500 under the terms of a Securities Purchase Agreement dated October 25, 2017, with Crown Bridge under which the Company issued to Crown Bridge a convertible note in the principal amount of $105,000 and a five-year warrant to purchase 100 shares of the Company’s common stock at an exercise price of $350 as a commitment fee which is equal to the product of one-third of the face value of each tranche divided by $0.35.
Series A Preferred Stock [Member]
Stockholders' Deficit (Details) [Line Items]
Preferred stock shares designated									250		250
Preferred stock, shares outstanding									250		250
Preferred stock, shares issued									250		250
Stock Option [Member]
Stockholders' Deficit (Details) [Line Items]
Compensation and consulting expense related to stock options (in Dollars)									$ 34,934	$ 39,435
Unrecognized compensation and consulting expense (in Dollars)									$ 42,369
Warrants [Member]
Stockholders' Deficit (Details) [Line Items]
Security purchase agreement, description								an additional 200 warrants were issued as a penalty and in order to entice Crown Bridge to waive its right of first refusal to provide additional financing under the terms of their convertible note. A debt discount of $44,036 was recorded for the relative fair market value of the total 300 warrants and amortized to interest expense as of September 30, 2018. The warrants have full ratchet price protection and cashless exercise rights (See Note10). The warrant includes an anti-dilution clause that was triggered on June 4, 2018. On June 4, 2018 an unrelated convertible note holder became entitled to convert their note into common shares at a 60% discount to the stock’s market price. The anti-dilution provision trigger in the warrant agreement entitled Crown Bridge to exercise its warrants under a formula that increased the number of common shares to 31,250 at a price of $3.60 per share. Due to the fact that the number of shares and exercise price can change due to market changes in the price of the common stock the Company has concluded to treat the warrants as derivatives and to revalue that derivative at each reporting date. Therefore a derivative liability of $261,484 with a charge to additional paid in capital was recorded on June 4, 2018. As of December 31, 2021, the warrant was revalued and the warrant holder is entitled to exercise its warrants for 119,777,075 common shares and the related derivative liability is $125,016.
Preferred Stock [Member]
Stockholders' Deficit (Details) [Line Items]
Preferred stock, shares authorized									5,000,000
Preferred stock, par value (in Dollars per share)									$ 0.0001
Preferred Stock [Member] | Series A Preferred Stock [Member]
Stockholders' Deficit (Details) [Line Items]
Preferred stock, par value (in Dollars per share)									$ 0.0001		$ 0.0001
Common Stock [Member]
Stockholders' Deficit (Details) [Line Items]
Reverse stock split, description					On August 6, 2019, the Company filed amendments with the Secretary of the State of Delaware, amending its articles of incorporation to execute a reverse stock split of 1 share for every 1,000 shares outstanding, and changing its name to Bantec, Inc. The name change and the stock split became effective in February 2020, and the transfer agent adjusted the outstanding shares for the reverse split on February 10, 2020.
Common Stock [Member] | Minimum [Member]
Stockholders' Deficit (Details) [Line Items]
Common stock, shares authorized												6,000,000,000
Common Stock [Member] | Maximum [Member]
Stockholders' Deficit (Details) [Line Items]
Common stock, shares authorized												1,500,000,000